Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 107, doi. 10.1007/s00262-002-0361-8
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2003 AND VI 52 AND IP 2
Results: 8
1
2
Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 116, doi. 10.1007/s00262-002-0344-9
- By:
- Publication type:
- Article
3
A novel adenovirus expressing human 4–1BB ligand enhances antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 97, doi. 10.1007/s00262-002-0334-y
- By:
- Publication type:
- Article
4
A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 121, doi. 10.1007/s00262-002-0363-6
- By:
- Publication type:
- Article
5
Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 127, doi. 10.1007/s00262-002-0342-y
- By:
- Publication type:
- Article
6
Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 67, doi. 10.1007/s00262-002-0338-7
- By:
- Publication type:
- Article
7
Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 80, doi. 10.1007/s00262-002-0335-x
- By:
- Publication type:
- Article
8
The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 89, doi. 10.1007/s00262-002-0362-7
- By:
- Publication type:
- Article